PIK3CA and prostate adenocarcinoma: Since CD133 can regulate the PI3k/Akt pathway in prostate adenocarcinoma cells [18], the TCGA-GBM dataset was studied to identify the correlations between CD133 and the genes of the PI3K/Akt and MAPK pathways.